
--- Page 1 ---
page 1 / 2 Department of Cancer Pathology copy No. Date: Examination: Intraoperative examination Internal invoice No. Cost of diagnostic procedure  Examination No.: Patient: xxx PESEL: XXX Age: Gender: F Material: Lesion resection - from the Ieft breast with -- outer qjuad. boundary Ics-0-3 Unit in charge: Cautinoma, mfiYtnatng ouet;no5 850of3 Physician in charge: Srte: srast,N0s C50.9 Material collected on: ' Material received on: Expected time of examination: 20 minutes (from receipt of the material) Clinical diagnosis: Cancer of the left breasty'Cancer of the left breast. Lesion on the boundary of outer quadrants. Marked typically. Please evaluate the margins. Examination performed on: Results of immunohistochemical examination: Part of the breast sized 9 x 7 x 4 cm with a skin flap of 5 x 1.5 cm. Margins: 1.3 cm to the base, 1.6 cm to the skin, 2.5 cm to the sternum, 2.5 cm to the axilla, 3 cm to the shoulder, 2 cm to the lower boundary Result of intraoperative examination: Carcinoma invasivum Compliance validated by:' Examination performed on: Macroscopic description: Part of the breast sized 9 x 7 x 4 cm with a skin flap of 5 x 1.5 cm. Margins: 1.3 cm to the base, 1.6 cm to the skin, 2.5 cm to the Sternum, 2.5 cm to the axilla, 3 cm to the shoulder, 2 cm to the lower boundary. Microscopic description: Carcinoma ductale invasivum - NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). Additionally, benign lesions of the type adenosis sclerosans et "blunt duet" and lymph node free of neoplastic metastasis. Margins as in the macroscopic description. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. (NHG2, pTIc, pNO /sn/) Invasive ductal carcinoma of the left breast. (NHG2, pTIc, pNO /sn/) Compliance validated by: Examination performed on: UUID:9320030D-5E19-4BEE-99DA-36686762DED1 TCGA-D8-A1XA-01A-PR Redacted nous Pril

--- Page 2 ---
page 2 / 2 Examination: Intraoperative examination Examination No.: Patient: xxx PESEL: XXX Gender: F Examination performed on: Result of immunohistochemical test: Estrogen receptors found in over 75% of neoplastic cell nuctei. Progesterone receptors found in over 75% of  neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive carcinoma cells ( Score = 1+ 1 Compliance validated by: CONTACT YOUR DOCTOR WITH THIS REPORT!